Prognostic Significance of FDG PET/CT in Esophageal Squamous Cell Carcinoma in the Era of the 8th AJCC/UICC Staging System

Recently, the American Joint Committee on Cancer (AJCC)/Union for International Cancer Control (UICC) staging system was updated for its 8th edition. F-18 fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) is a useful imaging tool to diagnose and predict prognoses for e...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in oncology Vol. 12; p. 861867
Main Authors Lee, Hyunjong, Lee, Kyung Soo, Min, Yang Won, Kim, Hong Kwan, Zo, Jae Ill, Shim, Young Mog, Choi, Joon Young
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 30.06.2022
Subjects
Online AccessGet full text
ISSN2234-943X
2234-943X
DOI10.3389/fonc.2022.861867

Cover

Abstract Recently, the American Joint Committee on Cancer (AJCC)/Union for International Cancer Control (UICC) staging system was updated for its 8th edition. F-18 fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) is a useful imaging tool to diagnose and predict prognoses for esophageal cancer. However, there was no previous study to explore the role of FDG PET/CT in the staging system based on the 8th edition. The prognostic value of FDG PET/CT was investigated in patients with esophageal squamous cell carcinoma (SqCC) considering the new 8th AJCC/UICC staging system. Subjects were 721 patients with esophageal SqCC undergoing pretherapeutic FDG PET/CT. Clinico-pathological variables and the maximum standardized uptake value (SUVmax) of the primary tumor were included in survival analysis. Subgroup analysis was performed to compare hazard ratios according to pathological stage and SUVmax. A new staging classification including FDG uptake was proposed. In multivariate survival analysis, pathological stage and SUVmax of the primary tumor were selected as independent prognostic factors for overall survival in both the 7th and 8th editions. The proposed new staging system showed better discrimination for overall survival between stage I and II than did the conventional staging system (hazard ratios: 2.250 vs. 1.341). The FDG uptake of the primary tumor was found to be an independent prognostic factor along with pathological stage based on both 7th and 8th AJCC/UICC staging systems in patients with esophageal SqCC. The suggested new staging system including SUVmax was better for predicting prognoses than the conventional staging system.
AbstractList IntroductionRecently, the American Joint Committee on Cancer (AJCC)/Union for International Cancer Control (UICC) staging system was updated for its 8th edition. F-18 fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) is a useful imaging tool to diagnose and predict prognoses for esophageal cancer. However, there was no previous study to explore the role of FDG PET/CT in the staging system based on the 8th edition. The prognostic value of FDG PET/CT was investigated in patients with esophageal squamous cell carcinoma (SqCC) considering the new 8th AJCC/UICC staging system.MethodsSubjects were 721 patients with esophageal SqCC undergoing pretherapeutic FDG PET/CT. Clinico-pathological variables and the maximum standardized uptake value (SUVmax) of the primary tumor were included in survival analysis. Subgroup analysis was performed to compare hazard ratios according to pathological stage and SUVmax. A new staging classification including FDG uptake was proposed.ResultsIn multivariate survival analysis, pathological stage and SUVmax of the primary tumor were selected as independent prognostic factors for overall survival in both the 7th and 8th editions. The proposed new staging system showed better discrimination for overall survival between stage I and II than did the conventional staging system (hazard ratios: 2.250 vs. 1.341).ConclusionsThe FDG uptake of the primary tumor was found to be an independent prognostic factor along with pathological stage based on both 7th and 8th AJCC/UICC staging systems in patients with esophageal SqCC. The suggested new staging system including SUVmax was better for predicting prognoses than the conventional staging system.
Recently, the American Joint Committee on Cancer (AJCC)/Union for International Cancer Control (UICC) staging system was updated for its 8th edition. F-18 fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) is a useful imaging tool to diagnose and predict prognoses for esophageal cancer. However, there was no previous study to explore the role of FDG PET/CT in the staging system based on the 8th edition. The prognostic value of FDG PET/CT was investigated in patients with esophageal squamous cell carcinoma (SqCC) considering the new 8th AJCC/UICC staging system. Subjects were 721 patients with esophageal SqCC undergoing pretherapeutic FDG PET/CT. Clinico-pathological variables and the maximum standardized uptake value (SUVmax) of the primary tumor were included in survival analysis. Subgroup analysis was performed to compare hazard ratios according to pathological stage and SUVmax. A new staging classification including FDG uptake was proposed. In multivariate survival analysis, pathological stage and SUVmax of the primary tumor were selected as independent prognostic factors for overall survival in both the 7th and 8th editions. The proposed new staging system showed better discrimination for overall survival between stage I and II than did the conventional staging system (hazard ratios: 2.250 vs. 1.341). The FDG uptake of the primary tumor was found to be an independent prognostic factor along with pathological stage based on both 7th and 8th AJCC/UICC staging systems in patients with esophageal SqCC. The suggested new staging system including SUVmax was better for predicting prognoses than the conventional staging system.
Recently, the American Joint Committee on Cancer (AJCC)/Union for International Cancer Control (UICC) staging system was updated for its 8th edition. F-18 fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) is a useful imaging tool to diagnose and predict prognoses for esophageal cancer. However, there was no previous study to explore the role of FDG PET/CT in the staging system based on the 8th edition. The prognostic value of FDG PET/CT was investigated in patients with esophageal squamous cell carcinoma (SqCC) considering the new 8th AJCC/UICC staging system.IntroductionRecently, the American Joint Committee on Cancer (AJCC)/Union for International Cancer Control (UICC) staging system was updated for its 8th edition. F-18 fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) is a useful imaging tool to diagnose and predict prognoses for esophageal cancer. However, there was no previous study to explore the role of FDG PET/CT in the staging system based on the 8th edition. The prognostic value of FDG PET/CT was investigated in patients with esophageal squamous cell carcinoma (SqCC) considering the new 8th AJCC/UICC staging system.Subjects were 721 patients with esophageal SqCC undergoing pretherapeutic FDG PET/CT. Clinico-pathological variables and the maximum standardized uptake value (SUVmax) of the primary tumor were included in survival analysis. Subgroup analysis was performed to compare hazard ratios according to pathological stage and SUVmax. A new staging classification including FDG uptake was proposed.MethodsSubjects were 721 patients with esophageal SqCC undergoing pretherapeutic FDG PET/CT. Clinico-pathological variables and the maximum standardized uptake value (SUVmax) of the primary tumor were included in survival analysis. Subgroup analysis was performed to compare hazard ratios according to pathological stage and SUVmax. A new staging classification including FDG uptake was proposed.In multivariate survival analysis, pathological stage and SUVmax of the primary tumor were selected as independent prognostic factors for overall survival in both the 7th and 8th editions. The proposed new staging system showed better discrimination for overall survival between stage I and II than did the conventional staging system (hazard ratios: 2.250 vs. 1.341).ResultsIn multivariate survival analysis, pathological stage and SUVmax of the primary tumor were selected as independent prognostic factors for overall survival in both the 7th and 8th editions. The proposed new staging system showed better discrimination for overall survival between stage I and II than did the conventional staging system (hazard ratios: 2.250 vs. 1.341).The FDG uptake of the primary tumor was found to be an independent prognostic factor along with pathological stage based on both 7th and 8th AJCC/UICC staging systems in patients with esophageal SqCC. The suggested new staging system including SUVmax was better for predicting prognoses than the conventional staging system.ConclusionsThe FDG uptake of the primary tumor was found to be an independent prognostic factor along with pathological stage based on both 7th and 8th AJCC/UICC staging systems in patients with esophageal SqCC. The suggested new staging system including SUVmax was better for predicting prognoses than the conventional staging system.
Author Min, Yang Won
Shim, Young Mog
Lee, Kyung Soo
Kim, Hong Kwan
Zo, Jae Ill
Lee, Hyunjong
Choi, Joon Young
AuthorAffiliation 1 Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine , Seoul , South Korea
4 Department of Thoracic Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine , Seoul , South Korea
2 Department of Radiology, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine , Seoul , South Korea
3 Division of Gastroenterology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine , Seoul , South Korea
AuthorAffiliation_xml – name: 1 Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine , Seoul , South Korea
– name: 3 Division of Gastroenterology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine , Seoul , South Korea
– name: 2 Department of Radiology, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine , Seoul , South Korea
– name: 4 Department of Thoracic Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine , Seoul , South Korea
Author_xml – sequence: 1
  givenname: Hyunjong
  surname: Lee
  fullname: Lee, Hyunjong
– sequence: 2
  givenname: Kyung Soo
  surname: Lee
  fullname: Lee, Kyung Soo
– sequence: 3
  givenname: Yang Won
  surname: Min
  fullname: Min, Yang Won
– sequence: 4
  givenname: Hong Kwan
  surname: Kim
  fullname: Kim, Hong Kwan
– sequence: 5
  givenname: Jae Ill
  surname: Zo
  fullname: Zo, Jae Ill
– sequence: 6
  givenname: Young Mog
  surname: Shim
  fullname: Shim, Young Mog
– sequence: 7
  givenname: Joon Young
  surname: Choi
  fullname: Choi, Joon Young
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35847839$$D View this record in MEDLINE/PubMed
BookMark eNp1Uk1r3DAQNSWlSdPceyo69rK7-rC00qUQnE26JdDAbqA3MZYlr4ItJZK3kP762t00JIXqMoPmvTea0XtfHIUYbFF8JHjOmFQLF4OZU0zpXAoixfJNcUIpK2eqZD-OXuTHxVnOd3g8gmOC2bvimHFZLiVTJ8WvmxTbEPPgDdr4NnjnDQRjUXTo8uIK3ay2i2qLfECrHO930Fro0OZhD33cZ1TZrkMVJOND7GFCDTuLVgkm-pTKYYfOv1XV4nZdVWgzQOtDizaPebD9h-Ktgy7bs6d4WtxerrbV19n196t1dX49M6Wgw6wGzBVIB0oJp3hTl0JY1UgKvHGMjAVBGmIdw8rUoiacE2mlNbSpLZOsZKfF-qDbRLjT98n3kB51BK__XMTUakjj_J3VQnIODQbBuSidhZpbJ2sqjOFqyZd21Ppy0Lrf171tjA1Dgu6V6OtK8Dvdxp9aUYmVJKPA5yeBFB_2Ng-699mMa4Rgx41qKhQpuSTLCfrpZa_nJn8_bwTgA8CkmHOy7hlCsJ4soieL6Mki-mCRkSL-oRg_wODj9Frf_Z_4G104wLg
CitedBy_id crossref_primary_10_1016_j_semradonc_2023_03_006
crossref_primary_10_1007_s00330_024_11207_3
crossref_primary_10_1186_s40644_024_00811_7
Cites_doi 10.3346/jkms.2016.31.1.39
10.4251/wjgo.v6.i5.139
10.1002/9780471420194.tnmc26.pub3
10.1136/gutjnl-2014-308124
10.1007/s00595-014-0965-6
10.1097/MEG.0b013e328323d6fa
10.1002/cncr.24399
10.3322/caac.21660
10.1186/s40644-019-0225-5
10.1148/radiol.2363041310
10.4251/wjgo.v6.i5.112
10.1177/107327481302000202
10.1007/s11605-009-1038-9
10.1016/j.suc.2012.07.013
10.2967/jnumed.114.148056
10.1245/s10434-011-1732-1
10.1097/01.mnm.0000134329.30912.49
10.1097/MNM.0b013e3282f81423
10.1097/RLU.0000000000002291
10.1007/s13139-020-00642-x
10.1259/bjr/73516936
10.1016/j.athoracsur.2006.03.045
10.1245/s10434-009-0719-7
10.1093/jjco/hyaa082
10.1016/j.ejso.2017.06.005
10.1097/MNM.0000000000000837
ContentType Journal Article
Copyright Copyright © 2022 Lee, Lee, Min, Kim, Zo, Shim and Choi.
Copyright © 2022 Lee, Lee, Min, Kim, Zo, Shim and Choi 2022 Lee, Lee, Min, Kim, Zo, Shim and Choi
Copyright_xml – notice: Copyright © 2022 Lee, Lee, Min, Kim, Zo, Shim and Choi.
– notice: Copyright © 2022 Lee, Lee, Min, Kim, Zo, Shim and Choi 2022 Lee, Lee, Min, Kim, Zo, Shim and Choi
DBID AAYXX
CITATION
NPM
7X8
5PM
DOA
DOI 10.3389/fonc.2022.861867
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList
PubMed
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2234-943X
ExternalDocumentID oai_doaj_org_article_6855ad0a65564feab5ef8b26cc59757e
PMC9280981
35847839
10_3389_fonc_2022_861867
Genre Journal Article
GroupedDBID 53G
5VS
9T4
AAFWJ
AAKDD
AAYXX
ACGFO
ACGFS
ADBBV
ADRAZ
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
CITATION
DIK
EBS
EJD
EMOBN
GROUPED_DOAJ
GX1
HYE
KQ8
M48
M~E
OK1
PGMZT
RNS
RPM
ACXDI
IPNFZ
NPM
RIG
7X8
5PM
ID FETCH-LOGICAL-c462t-ba059a8fa996f95db466e9d82a5df318fa61d1ef309cb6b15518e8ec2dbe38343
IEDL.DBID M48
ISSN 2234-943X
IngestDate Wed Aug 27 01:30:15 EDT 2025
Thu Aug 21 18:28:37 EDT 2025
Fri Sep 05 09:59:47 EDT 2025
Mon Jul 21 06:05:36 EDT 2025
Wed Oct 01 01:24:59 EDT 2025
Thu Apr 24 23:04:20 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords 8th AJCC staging system
esophageal cancer
FDG PET/CT
prognosis
squamous cell carcinoma
Language English
License Copyright © 2022 Lee, Lee, Min, Kim, Zo, Shim and Choi.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c462t-ba059a8fa996f95db466e9d82a5df318fa61d1ef309cb6b15518e8ec2dbe38343
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Edited by: Alessio G. Morganti, University of Bologna, Italy
This article was submitted to Gastrointestinal Cancers: Gastric & Esophageal Cancers, a section of the journal Frontiers in Oncology
Reviewed by: Long-Qi Chen, Sichuan University, China; Guobing Liu, Fudan University, China
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3389/fonc.2022.861867
PMID 35847839
PQID 2691458171
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_6855ad0a65564feab5ef8b26cc59757e
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9280981
proquest_miscellaneous_2691458171
pubmed_primary_35847839
crossref_primary_10_3389_fonc_2022_861867
crossref_citationtrail_10_3389_fonc_2022_861867
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2022-06-30
PublicationDateYYYYMMDD 2022-06-30
PublicationDate_xml – month: 06
  year: 2022
  text: 2022-06-30
  day: 30
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
PublicationTitle Frontiers in oncology
PublicationTitleAlternate Front Oncol
PublicationYear 2022
Publisher Frontiers Media S.A
Publisher_xml – name: Frontiers Media S.A
References Shim (B13) 2005; 236
B27
Kato (B25) 2009; 115
Yildirim (B17) 2018; 39
Omloo (B20) 2011; 18
Napier (B3) 2014; 6
Karashima (B6) 2015; 45
Brierley (B10) 2017
Almhanna (B4) 2013; 20
Sung (B1) 2021; 71
Cerfolio (B22) 2006; 82
Zhang (B26) 2017; 43
Sepesi (B24) 2009; 13
Sunderland (B28) 2015; 56
Park (B15) 2020; 54
Al-Taan (B21) 2014; 6
Arnold (B2) 2015; 64
Lee (B8) 2019; 19
Daiko (B11) 2020; 50
Lucignani (B14) 2004; 25
Cheze-Le Rest (B23) 2008; 29
Heeren (B7) 2004; 45
Pan (B9) 2009; 21
Kim (B12) 2012; 85
Hong (B18) 2016; 31
Han (B16) 2018; 43
Hyun (B19) 2010; 17
Cooper (B5) 2012; 92
39529838 - Front Oncol. 2024 Oct 28;14:1505996. doi: 10.3389/fonc.2024.1505996
References_xml – volume: 45
  year: 2004
  ident: B7
  article-title: Detection of Distant Metastases in Esophageal Cancer With 18F-FDG PET
  publication-title: J Nucl Med
– volume: 31
  start-page: 39
  year: 2016
  ident: B18
  article-title: Total Lesion Glycolysis Using 18F-FDG PET/CT as a Prognostic Factor for Locally Advanced Esophageal Cancer
  publication-title: J Korean Med Sci
  doi: 10.3346/jkms.2016.31.1.39
– volume: 6
  year: 2014
  ident: B21
  article-title: Prognostic Value of Baseline FDG Uptake on PET-CT in Esophageal Carcinoma
  publication-title: World J Gastrointest Oncol
  doi: 10.4251/wjgo.v6.i5.139
– start-page: 57
  year: 2017
  ident: B10
  article-title: TNM Classification of Malignant Tumours: John Wiley & Sons
  doi: 10.1002/9780471420194.tnmc26.pub3
– volume: 64
  year: 2015
  ident: B2
  article-title: Global Incidence of Oesophageal Cancer by Histological Subtype in 2012
  publication-title: Gut
  doi: 10.1136/gutjnl-2014-308124
– volume: 45
  year: 2015
  ident: B6
  article-title: Advantages of FDG-PET/CT Over CT Alone in the Preoperative Assessment of Lymph Node Metastasis in Patients With Esophageal Cancer
  publication-title: Surg Today
  doi: 10.1007/s00595-014-0965-6
– volume: 21
  year: 2009
  ident: B9
  article-title: Prognostic Significance of SUV on PET/CT in Patients With Esophageal Cancer: A Systematic Review and Meta-Analysis
  publication-title: Eur J Gastroenterol Hepatol
  doi: 10.1097/MEG.0b013e328323d6fa
– ident: B27
– volume: 115
  year: 2009
  ident: B25
  article-title: The Clinical Application of 18F-Fluorodeoxyglucose Positron Emission Tomography to Predict Survival in Patients With Operable Esophageal Cancer
  publication-title: Cancer
  doi: 10.1002/cncr.24399
– volume: 71
  year: 2021
  ident: B1
  article-title: Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
  publication-title: CA Cancer J Clin
  doi: 10.3322/caac.21660
– volume: 19
  start-page: 40
  year: 2019
  ident: B8
  article-title: Improved Detection of Metastatic Lymph Nodes in Oesophageal Squamous Cell Carcinoma by Combined Interpretation of Fluorine-18-Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography
  publication-title: Cancer Imaging
  doi: 10.1186/s40644-019-0225-5
– volume: 236
  year: 2005
  ident: B13
  article-title: Non–small Cell Lung Cancer: Prospective Comparison of Integrated FDG PET/CT and CT Alone for Preoperative Staging
  publication-title: Radiology
  doi: 10.1148/radiol.2363041310
– volume: 6
  year: 2014
  ident: B3
  article-title: Esophageal Cancer: A Review of Epidemiology, Pathogenesis, Staging Workup and Treatment Modalities
  publication-title: World J Gastrointest Oncol
  doi: 10.4251/wjgo.v6.i5.112
– volume: 20
  start-page: 89
  year: 2013
  ident: B4
  article-title: Neoadjuvant or Adjuvant Therapy for Resectable Esophageal Cancer: Is There a Standard of Care
  publication-title: Cancer Control
  doi: 10.1177/107327481302000202
– volume: 13
  year: 2009
  ident: B24
  article-title: Does the Value of PET-CT Extend Beyond Pretreatment Staging? An Analysis of Survival in Surgical Patients With Esophageal Cancer
  publication-title: J Gastrointest Surg
  doi: 10.1007/s11605-009-1038-9
– volume: 92
  year: 2012
  ident: B5
  article-title: Definitive Chemoradiotherapy for Esophageal Carcinoma
  publication-title: Surg Clin North Am
  doi: 10.1016/j.suc.2012.07.013
– volume: 56
  year: 2015
  ident: B28
  article-title: Quantitative PET/CT Scanner Performance Characterization Based Upon the Society of Nuclear Medicine and Molecular Imaging Clinical Trials Network Oncology Clinical Simulator Phantom
  publication-title: J Nucl Med
  doi: 10.2967/jnumed.114.148056
– volume: 18
  year: 2011
  ident: B20
  article-title: FDG-PET Parameters as Prognostic Factor in Esophageal Cancer Patients: A Review
  publication-title: Ann Surg Oncol
  doi: 10.1245/s10434-011-1732-1
– volume: 25
  year: 2004
  ident: B14
  article-title: The Use of Standardized Uptake Values for Assessing FDG Uptake With PET in Oncology: A Clinical Perspective
  publication-title: Nucl Med Commun
  doi: 10.1097/01.mnm.0000134329.30912.49
– volume: 29
  year: 2008
  ident: B23
  article-title: Prognostic Value of Initial Fluorodeoxyglucose-PET in Esophageal Cancer: A Prospective Study
  publication-title: Nucl Med Commun
  doi: 10.1097/MNM.0b013e3282f81423
– volume: 43
  year: 2018
  ident: B16
  article-title: Prognostic Value of Volumetric Parameters of Pretreatment 18F-FDG PET/CT in Esophageal Cancer: A Systematic Review and Meta-Analysis
  publication-title: Clin Nucl Med
  doi: 10.1097/RLU.0000000000002291
– volume: 54
  year: 2020
  ident: B15
  article-title: Radiogenomics Based on PET Imaging
  publication-title: Nucl Med Mol Imaging
  doi: 10.1007/s13139-020-00642-x
– volume: 85
  year: 2012
  ident: B12
  article-title: Hounsfield Units Upon PET/CT are Useful in Evaluating Metastatic Regional Lymph Nodes in Patients With Oesophageal Squamous Cell Carcinoma
  publication-title: Br J Radiol
  doi: 10.1259/bjr/73516936
– volume: 82
  year: 2006
  ident: B22
  article-title: Maximum Standardized Uptake Values on Positron Emission Tomography of Esophageal Cancer Predicts Stage, Tumor Biology, and Survival
  publication-title: Ann Thorac Surg
  doi: 10.1016/j.athoracsur.2006.03.045
– volume: 17
  year: 2010
  ident: B19
  article-title: Prognostic Value of Metabolic Tumor Volume Measured by 18F-Fluorodeoxyglucose Positron Emission Tomography in Patients With Esophageal Carcinoma
  publication-title: Ann Surg Oncol
  doi: 10.1245/s10434-009-0719-7
– volume: 50
  year: 2020
  ident: B11
  article-title: Updates in the 8th Edition of the TNM Staging System for Esophagus and Esophagogastric Junction Cancer
  publication-title: Jpn J Clin Oncol
  doi: 10.1093/jjco/hyaa082
– volume: 43
  year: 2017
  ident: B26
  article-title: Comparison of the 7th and Proposed 8th Editions of the AJCC/UICC TNM Staging System for Esophageal Squamous Cell Carcinoma Underwent Radical Surgery
  publication-title: Eur J Surg Oncol
  doi: 10.1016/j.ejso.2017.06.005
– volume: 39
  year: 2018
  ident: B17
  article-title: Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis in Esophageal Carcinoma Patients Treated With Definitive Chemoradiotherapy
  publication-title: Nucl Med Commun
  doi: 10.1097/MNM.0000000000000837
– reference: 39529838 - Front Oncol. 2024 Oct 28;14:1505996. doi: 10.3389/fonc.2024.1505996
SSID ssj0000650103
Score 2.3228774
Snippet Recently, the American Joint Committee on Cancer (AJCC)/Union for International Cancer Control (UICC) staging system was updated for its 8th edition. F-18...
IntroductionRecently, the American Joint Committee on Cancer (AJCC)/Union for International Cancer Control (UICC) staging system was updated for its 8th...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 861867
SubjectTerms 8th AJCC staging system
esophageal cancer
FDG PET/CT
Oncology
prognosis
squamous cell carcinoma
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nb9QwELVQD4gLonyGAjISFw4hiWM79rGEXUolUKXuSr1ZtmPTlZYEVtsLv56ZOF3tIgQXblFiO9bM2PNGM3pDyBurm1KBn8ltxyFAEZ3MHTLQ1k6r2grMnI1Vvl_k2ZKfX4mrvVZfWBOW6IGT4AqphLBdaaUQksdgnQhROSa9BygsmoC3L7ixvWAq3cECGxikvCREYbqIQ4-MhYy9U0gR3xz4oZGu_08Y8_dSyT3fM39A7k-gkZ6mzR6TO6F_SO5-ntLij8jPi82ABXPwmV6uvvZY_oPapEOk8w8f6cVsUbQLuurpDLsWwBUCq13-uLEY99M2rNe0xZ5C_fDN4igAhXS2sTgdH9X2mp6et22x_NS2FOApNjaiiev8MVnOZ4v2LJ-aKuSeS7bNnQVAZVW0EOhELTrHpQy6U8yKLsIBj1ZWXRViXWrvpBsZ24IKnnUuQDTL6yfkqB_68IxQAGuqY942VivuBXcKwIBnsfRVA4u4jBS3IjZ-YhzHxhdrA5EHKsWgUgwqxSSlZOTtbsb3xLbxl7HvUWu7cciTPb4A6zGT9Zh_WU9GXt_q3MC5wmSJ7QPI3jCpKy5U1VQZeZpsYPerGnPLgCwz0hxYx8FeDr_0q-uRu1szVWpVPf8fmz8h91AeqXrxBTnabm7CS4BIW_dqPA2_ACkZDfc
  priority: 102
  providerName: Directory of Open Access Journals
Title Prognostic Significance of FDG PET/CT in Esophageal Squamous Cell Carcinoma in the Era of the 8th AJCC/UICC Staging System
URI https://www.ncbi.nlm.nih.gov/pubmed/35847839
https://www.proquest.com/docview/2691458171
https://pubmed.ncbi.nlm.nih.gov/PMC9280981
https://doaj.org/article/6855ad0a65564feab5ef8b26cc59757e
Volume 12
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 2234-943X
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000650103
  issn: 2234-943X
  databaseCode: KQ8
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 2234-943X
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000650103
  issn: 2234-943X
  databaseCode: DOA
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 2234-943X
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000650103
  issn: 2234-943X
  databaseCode: DIK
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVFQY
  databaseName: GFMER Free Medical Journals
  customDbUrl:
  eissn: 2234-943X
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000650103
  issn: 2234-943X
  databaseCode: GX1
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php
  providerName: Geneva Foundation for Medical Education and Research
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 2234-943X
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000650103
  issn: 2234-943X
  databaseCode: M~E
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVAQN
  databaseName: PubMed Central
  customDbUrl:
  eissn: 2234-943X
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0000650103
  issn: 2234-943X
  databaseCode: RPM
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
– providerCode: PRVFZP
  databaseName: Scholars Portal Journals: Open Access
  customDbUrl:
  eissn: 2234-943X
  dateEnd: 20250131
  omitProxy: true
  ssIdentifier: ssj0000650103
  issn: 2234-943X
  databaseCode: M48
  dateStart: 20110601
  isFulltext: true
  titleUrlDefault: http://journals.scholarsportal.info
  providerName: Scholars Portal
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3db9MwELdgSIgXxPcyYDISLzxkTRzbsR8QGqHdmDQ0aa3Ut8h27K1SSbbQScBfz12SFYoqJF6ifDhO4rN9v_NdfkfIW6PzRIGeiU3FwUARlYwtMtBmVqvMCPScdVG-X-TxjJ_Mxfz379FDA37batphPqlZuzz4fv3jAwz492hxgr4dhaZGMkLGDhSyv-d3yT3QSwz7-OkA9vt5WWBSA8w2xzIea57Ne7_l1ko29FRH578Ng_4dSvmHbpo8Ig8HUEkP-17wmNzx9RNy_3Rwmz8lP8_aBgPq4DI9X1zUGB6E0qZNoJNPR_RsPB0VU7qo6RizGsAUA7WdX98YXBeghV8uaYE5h-rmq8FSABrpuDV4O-6q1SU9PCmK0exzUVCAr5j4iPZc6M_IbDKeFsfxkHQhdlyyVWwNAC6jggFDKGhRWS6l15ViRlQBJoBgZFqlPmSJdlbajtHNK-9YZT1Yuzx7Tnbqpva7hAKYUxVzJjdacSe4VQAWHAuJS3OoxEZkdNvEpRsYyTExxrIEywSFUqJQShRK2QslIu_Wd1z1bBz_KPsRpbYuhzza3YmmvSiHYVlKJYSpEiOFkDx4Y4UPyjLpHBhaIvcReXMr8xLGHTpTTO2h7UsmdcqFSvM0Ii_6PrB-VIa-Z0CeEck3esfGu2xeqReXHbe3ZirRKt37jw99SR7gUR_E-IrsrNob_xqQ0srudysMsD2ap_vdYPgFefcQGA
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prognostic+Significance+of+FDG+PET%2FCT+in+Esophageal+Squamous+Cell+Carcinoma+in+the+Era+of+the+8th+AJCC%2FUICC+Staging+System&rft.jtitle=Frontiers+in+oncology&rft.au=Lee%2C+Hyunjong&rft.au=Lee%2C+Kyung+Soo&rft.au=Min%2C+Yang+Won&rft.au=Kim%2C+Hong+Kwan&rft.date=2022-06-30&rft.issn=2234-943X&rft.eissn=2234-943X&rft.volume=12&rft_id=info:doi/10.3389%2Ffonc.2022.861867&rft.externalDBID=n%2Fa&rft.externalDocID=10_3389_fonc_2022_861867
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2234-943X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2234-943X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2234-943X&client=summon